-
Beijing Balance Medical Secures NMPA Nod for Renatus Transcatheter Aortic Valve System
•
BEIJING—Beijing Balance Medical Technology Co., Ltd (SHA: 688198) has received market approval from the National Medical Products Administration (NMPA) for its Renatus transcatheter aortic valve system. This in-house developed product is now approved for use in patients aged 70 years or older who are diagnosed with symptomatic, calcified, and severe…
-
Beijing Balance Medical Secures NMPA Nod for Pioneering Heart Valve Patch
•
Beijing Balance Medical Technology Co., Ltd (SHA: 688198), a leading medical technology firm based in China, has achieved a significant regulatory milestone with the National Medical Products Administration’s (NMPA) approval for its heart valve biological patch. This marks the first market approval for a product specifically designed for the repair…
-
Beijing Balance Medical Secures NMPA Approval for Innovative Mitral Valve Annuloplasty Ring
•
Beijing Balance Medical Technology Co., Ltd (SHA: 688198), a Chinese medical device company, has received market approval from the National Medical Products Administration (NMPA) for its proprietary mitral valve annuloplasty ring product. This development marks a significant milestone for the company, which aims to provide advanced cardiac solutions to patients.…
-
Beijing Balance Medical Technology’s Transcatheter Aortic Valve System Accepted for NMPA Review
•
China’s Beijing Balance Medical Technology Co., Ltd (SHA: 688198) has announced that the National Medical Products Administration (NMPA) has accepted its market approval filing for a transcatheter aortic valve system for review. Product Features and Clinical ApplicationsThe product is designed for patients with severe aortic valve stenosis who are at…
